Youming Ding

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation

Feng Guan, Youming Ding, Yemin Zhang et al. · PLoS ONE · 2016 · 140 citations · Full text

Mitophagy, Cell Death, Cancer Biology +19

New classification of the anatomic variations of cystic artery during laparoscopic cholecystectomy

Youming Ding · World Journal of Gastroenterology · 2007 · 91 citations · Full text

Expression and significance of MMP2 and HIF-1α in hepatocellular carcinoma

Bin Wang, Youming Ding, Ping Fan et al. · Oncology Letters · 2014 · 57 citations · Full text

Oncology, Hepatology, Hcc Tissues +15

Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells

Youming Ding, Bin Wang, Bin Yu et al. · European Journal of Pharmacology · 2018 · 55 citations

Oncology, Signaling Pathway, Inhibits Wnt/notch1 +13